CHLAMYDIAL INFECTION: DIAGNOSIS, TREATMENT (ACCORDING TO THE PROCEEDINGS OF THE 13 th INTERNATIONAL SYMPOSIUM, CALIFORNIA, 22-27 JUNE 2014)


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The purpose of the study was to analyze the results of the International Symposium on Human Chlamydial Infection. Molecular biology and genomics, cell biology, diagnosis, immunology, and responses to chlamydial infection, as well as sexually transmitted infections were the major matters considered at the congress.

Texto integral

Acesso é fechado

Sobre autores

Svetlana Dubrovina

Rostov Research Institute of Obstetrics and Pediatrics, Ministry of Health of Russia; Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don 344022

Email: s.dubrovina@gmail.com
MD, the main researcher; professor of the department of obstetrics and gynecology №1 344012, Russia, Rostov-on-Don, Mechnikova str. 43

Bibliografia

  1. Dubrovina S., Lesovaya V. Deoxyribonucleic acid of different sexual transmitted infections in the Fallopian tubes of patients with ectopic pregnancy. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 375-8.
  2. Schancher J. Diagnosis of Chlamydia trachomatis infection. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 187- 196.
  3. Muvunyi C.M., Claeys L., De Sutter T., De Sutter P., Temmerman M., Van Renterghem L. et al. Comparison of four serological assays for the diagnosis of Chlamydia trachomatis in subfertile women. J. Infect. Dev. Ctries. 2012; 6(5): 396-402.
  4. Frikha-Gargouri O., Gdoura R., Znazen A., Gargouri J., Hammami A. Diagnostic value of enzyme-linked immunosorbent assays using hypothetical proteins CT226 and CT795 as antigens in Chlamydia trachomatis serodiagnosis. Diagn. Microbiol. Infect. Dis. 2009; 65(3): 224-31.
  5. CoppusS.F., LandJ.A., Opmeer B.C., SteuresP., EijkemansM.J., HompesP.G. et al. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology. Hum. Reprod. 2011; 26(11): 3061-7.
  6. Menon S., Stansfield S., Allan J., Rombauts L., Weston G., Alexander K. et al. Development of a multi-antigen peptide ELISA for Chlamydial infertility. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 225-8.
  7. Joki-Korpela P., Rantsi T., Ohman H., Puolakkainen M., Bloigu A., Paavonen J. et al. Does immune response to Chlamydia trachomatis predict tubal factor infertility, a prospective study. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 387-90.
  8. Rantsi P., Joki-Korpela P., Wikstrom E., Ohman H., Bloigu A., Lehtinen et al. Population-based study on Chlamydia trachomatis associated risk of ectopic pregnancy and miscarriage during one decade. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 351-4.
  9. Puolakkainen M., Lehtinen M., Korhonen S., Paavonen J. Chlamydial serology - a useful tool in the laboratory diagnosis of persistent chlamydial infection? In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 233-6.
  10. Becker E., Hegemann J.H. All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 137-40.
  11. Timms P, Vaughan L., Polkinghorne A., Greub G. Chlamydia-like organisms: an axpanding concern or just a window on the past. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 3-12.
  12. Olsen A.W, Lorenzen E., Follmann F., Andersen P. A polyprotein vaccine promotes strong TH1 and neutralizing antibody responses and confers efficient protection against genital C. trachomatis infection in mice and pigs. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 265-8.
  13. Roan N.R., Starnbach M.N. Immune-mediated control of Chlamydia infection. Cell. Microbiol. 2008; 10(1): 9-19.
  14. Su H., Feilzer K, Caldwell H.D., Morrison R.P. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 1997; 65(6): 1993-9.
  15. Lin-Xi Li, McSolvey S.J. Antibody, but not B cell-dependent antigen presentation, is required for preventing bacteria dissemination following Chlamydia muridarum genital tract infection. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 273-6.
  16. de la Maza L.M. Progress in Chlamydia vaccinology. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 281-90.
  17. O’Connell C.M., Ingalls R.R., Andrews C.W. Jr., Scurlock A.M., Darville T. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 2007; 179(6): 4027-34.
  18. Farris C.M., Morrison R.P. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect. Immun. 2011; 79(3): 986-96.
  19. Pickett M.A., Everson J.S., Pead P.J., Clarke I.N. The plasmid of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents. Microbiology. 2005; 151(3): 893-903.
  20. Seth-Smith H.M., Harris S.R., Persson K., Marsh P, Barron A., Bignell A. et al. Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain. BMC Genomics. 2009; 10: 239.
  21. Bjartling C., Sundler M. The new Swedish variant of Chlamydia trachomatis and pelvic inflammatory disease in the South of Sweden. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 343-6.
  22. Gong Z., Luna Y., Zhong G., Fan H. pH-dependent Chlamydiacidal effects of Lactobacilli. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 81-4.
  23. St Amant D.C., Valentin-Bon I.E., Jerse A.E. Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infect. Immun. 2002; 70(12): 7169-71.
  24. Vodstrcil L.A., Rupasinghe D., Tull D., Worthington K., Chen M. Y., Huston W.M. et al. Post-treatment detection of azithromycin in high- vaginal swabs using liquid chromatography and tandem mass spectromery (LC-MSMS). Sex. Transm. Infect. 2013; 89(1): А113.
  25. Martin I., Sawatzky P., Liu G., Lefebvre B., Lovgren M., Allen V. et al. Azithromycin susceptibilities in Canadian Nesseria gonorrhoeae isolates (2010-2011). Sex. Transm. Infect. 2013; 89(1): А235.
  26. Kong F.Y.S., Vodstrcil L.A., Tabrizi S., Fairley C.K., Huston W., Chen M. et al. Efficacy of azithromycin for the treatment of rectal Chlamydia infection - a systematic review and meta-analysis. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 355-7.
  27. Workowski K.A., Berman S.; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm. Rep. 2010; 59(RR-12): 1-110.
  28. Batteiger B.E., Tu W, Ofner S., Van Der Pol B., Stothard D.R., Orr D.P. et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J. Infect. Dis. 2010; 201(1): 42-51.
  29. Huston W.M., LawrenceA.R., TimmsP., VodstrcilL.A., TabriziS.N., Chen M.Y. et al. Chlamydial population heterogenetity occurs in vivo and may be the mechanism of azithromycin treatment failure. In: Proceedings of the 13th International Symposium on Human Chlamydial Infections. Asilomar Conference Grounds, Pacific Grove, California June 22-27 2014. San Francisco; 2014: 359-62.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2015

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies